Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01831076Phase 2Completed
A Phase 2 trial of exemestane in breast cancer, sponsored by University of Colorado Denver. Started Apr 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01831076.